Creating Value: Private Equity, Venture Capital and Entrepreneurism

This course is intended for students interested in learning more about creating and building private equity backed companies, either directly as a principal or as an advisor.  The course will take a practical and interactive approach on how venture capital and buyout companies are formed and scale, focusing on three main stages of development: (1) Formation; (2) Growth; and (3) Exit.  Among the topics that will be covered are company formation (including term sheets and financing documents), scaling through M&A and organic growth, and liquidity events (IPO and sale).  The course will have guest speakers, utilize case studies, and employ a project-based approach.  If you want to learn more about the private equity process, this course is for you.

The course is open to Stanford Law and GSB students.

LAW 1084 | 2 Units | Grading: Law Mandatory P/R/F

Instructor

Mark Blumling

Mark Blumling

  • Serial Founder and CEO

A passionate advocate of healthcare and life sciences innovation, Mark has devoted his career to improving population health and patient outcomes. Mark was most recently CEO, President and Founder at Headlands Research, an international clinical trial site organization, and previously, CEO of Genos, a healthcare big data company (which he co-founded and which was acquired in 2017), CEO of Relevare Pharmaceuticals (a drug development pharmaceutical company based in San Francisco and Australia), and Founder and COO of Hyperion Therapeutics (NASDAQ: HPTX; acquired in 2015). Mark began his career in the Office of Science & Technology at SmithKline Beecham, where he was involved in the creation and development of new business ventures, and at Orchid Biosciences (NASDAQ: ORCH), where he helped lead the company’s successful turnaround. Mark was also an investor, focused on venture capital, growth equity and special situations, at Burrill & Company.

Mark received a JD from Stanford Law School, an MSc (Economics) from the London School of Economics, and a BA in Human Biology from Stanford University. He is a Member of the Council on Foreign Relations.